Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
December 28, 2023
Correction: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time
Andrew I Stolbach, Maryann Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
December 27, 2024
ACMT Position Statement: No Evidence that Tampons Cause Metal Poisoning
Mehruba Anwar Parris, Maryann Mazer-Amirshahi, Diane P Calello, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
November 30, 2023
American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time
Andrew I Stolbach, Maryann Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
April 18, 2024
ACMT Comment on Recent Guidance on PFAS Laboratory Testing
John W Downs, Nicholas E Nacca, Andrew I Stolbach, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
May 18, 2020
ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic
Maryann Mazer-Amirshahi, Erin R Fox, Brenna Michelle Farmer, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
July 1, 2020
ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use
Maryann Mazer-Amirshahi, Fiona M Garlich, Diane P Calello, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
January 16, 2020
ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites
Nicholas Connors, Michael J Kosnett, Ken Kulig, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
December 1, 2023
American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time
Andrew I Stolbach, Maryann E Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
June 6, 2020
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
Andrew I Stolbach, Maryann Mazer-Amirshahi, Ryan Marino, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
February 23, 2024
Ensuring the Efficacy and Safety of Approved Medications
Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
December 28, 2023
Correction: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time
Andrew I Stolbach, Maryann Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
December 27, 2024
ACMT Position Statement: No Evidence that Tampons Cause Metal Poisoning
Mehruba Anwar Parris, Maryann Mazer-Amirshahi, Diane P Calello, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
November 30, 2023
American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time
Andrew I Stolbach, Maryann Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
April 18, 2024
ACMT Comment on Recent Guidance on PFAS Laboratory Testing
John W Downs, Nicholas E Nacca, Andrew I Stolbach, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
May 18, 2020
ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic
Maryann Mazer-Amirshahi, Erin R Fox, Brenna Michelle Farmer, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
July 1, 2020
ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use
Maryann Mazer-Amirshahi, Fiona M Garlich, Diane P Calello, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
January 16, 2020
ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites
Nicholas Connors, Michael J Kosnett, Ken Kulig, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
December 1, 2023
American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time
Andrew I Stolbach, Maryann E Mazer-Amirshahi, Lewis S Nelson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
June 6, 2020
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
Andrew I Stolbach, Maryann Mazer-Amirshahi, Ryan Marino, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology
|
February 23, 2024
Ensuring the Efficacy and Safety of Approved Medications
Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, et al.
Page
of 4